[1]
NURHIDAYAH, M., FADILAH, F., ARSIANTI, A. and BAHTIAR, A. 2022. IDENTIFICATION OF FGFR INHIBITOR AS ST2 RECEPTOR/INTERLEUKIN-1 RECEPTOR-LIKE 1 INHIBITOR IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE DUE TO EXPOSURE TO E-CIGARETTES BY NETWORK PHARMACOLOGY AND MOLECULAR DOCKING PREDICTION. International Journal of Applied Pharmaceutics. 14, 2 (Mar. 2022), 256–266. DOI:https://doi.org/10.22159/ijap.2022v14i2.43784.